Pinsent Masons advises Teva on £603 million sale of Actavis’ UK and Ireland generics business

Israel-headquartered Teva is a leading global pharmaceutical company and the world’s largest generic medicines producer, whose generic portfolio covers nearly every therapeutic area.

The Pinsent Masons team was led by life sciences partner, Allistair Booth and corporate partner Andrew Hornigold. The core team of Joe Sandys, Adam Coughlin, Jennifer Hopkins, Allison Sadick, Louise Fullwood, Zara Early, Tom Watkins, Christopher Sharp, Deborah Bould, Nick Stones, Eloise Walker, Satvi Veepa, Giles Warrington, Richard Snape, Ellie Okereke, Stephen Cochrane, Genna Oakes, Matthew Cooper, Fiona Kindness, Charles Waddell, Thilo Schneider, Ciaran Wilkinson, Joss Ealey, Helen Connor and Cat Sibthrop played a pivotal role in getting the deal over the line.

Commenting on the deal, Allistair Booth, said: "We are delighted to have advised Teva on this deal at such an important time for the business.”